(R)-ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 1g

2,4-Dichlorocinnamic acid, 95.0%, 5g

5-CHLORO-2-(5-METHYL-1,4-DIAZEPAN-1-YL)BENZO[D]OXAZOLE, 95.0%, 100mg

p-Fluorophenyltrimethylsilane, 95%, 250mg

4,6-DICHLORO-2-(4-METHOXYBENZYL)PYRIMIDINE, 95%, 1g

Salicylaldehyde, min. 99%, for synthesis, 100 ml, glass packaging

Methyltetrazine-PEG5-NHS ester, 100mg

(S)-tert-Butyl (1-amino-3-(4-bromophenyl)-1-oxopropan-2-yl)carbamate, 95+%, 100mg

4-methyl-1,5,6,7-tetrahydro-2H-cyclopenta[d]pyrimidin-2-one, 95.0%, 250mg

2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one, 95.0%, 100g

Sodium L-Ascorbate>98.0%(T)500g

Methyl 7-bromoquinoline-3-carboxylate, 95.0%, 250mg

1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid, 97%, 25g